Posted in

Department News

UF Health Pathology Laboratories’ Tumor Mutation Analysis by Next-Generation Sequencing (NGS) now evaluates 33 genes. (references UF Health Pathology Laboratories Medical Director Robert W. Allan, M.D., and Molecular Pathology Director Petr Starostik, M.D.)

To: All involved in patient care From: Petr Starostik, MDMolecular Pathology DirectorUF Health Pathology Laboratories Robert W. Allan, MDMedical DirectorUF Health Pathology Laboratories Re: Expanded Tumor Mutation Analysis by Next-Generation Sequencing (NGS) (version 2.0) at UF Health Pathology Laboratories Starting July 13, 2015,…